Direkt zum Inhalt
Merck

Otitis media.

Pediatric clinics of North America (2013-03-14)
Michael E Pichichero
ZUSAMMENFASSUNG

Acute otitis media (AOM) is diagnosed based on visualization of a full or bulging tympanic membrane with middle ear effusion. The distribution of bacteria causing AOM in North America under the influence of pneumococcal conjugate vaccination and antibiotic selection pressure has resulted in a predominance of β-lactamase-producing Haemophilus influenzae followed by penicillin-resistant Streptococcus pneumoniae. Although guidelines continue to endorse amoxicillin as the preferred treatment, amoxicillin/clavulanate in high dosage would be the preferred treatment based on the otopathogen mix currently. Antibiotic prophylaxis has fallen into disfavor as a preventative strategy for AOM recurrences.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Amoxicillin, 95.0-102.0% anhydrous basis
Supelco
Amoxicillin Trihydrat, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Cefpodoximproxetil, United States Pharmacopeia (USP) Reference Standard
Supelco
Amoxicillin Trihydrat, VETRANAL®, analytical standard
Supelco
Cefuroxim, VETRANAL®, analytical standard
Cefpodoximproxetil, European Pharmacopoeia (EP) Reference Standard
Cefpodoximproxetil für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Cefpodoximproxetil für die Identifizierung von Unreinheit H, European Pharmacopoeia (EP) Reference Standard